Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Medicina (Kaunas) ; 59(9)2023 Sep 17.
Artículo en Inglés | MEDLINE | ID: mdl-37763795

RESUMEN

Background and Objectives: Thermal skin injuries are a prevalent cause of skin damage, potentially leading to severe morbidity and significant mortality. In this study, we intended to estimate the effects of HBO (hyperbaric oxygen treatment) and antioxidant supplementation with Filipendula ulmaria extract, individually and simultaneously, in the treatment of thermal skin injuries. Materials and Methods: As a thermal skin injury experimental model, we used two-month-old male Wistar albino rats. Thermal injuries were made with a solid aluminium bar at a constant temperature of 75 °C for 15 s. Hyperbaric oxygen treatment was performed in a specially constructed hyperbaric chamber for rats (HYB-C 300) for seven consecutive days (100% O2 at 2.5 ATA for 60 min). Antioxidant supplementation was performed with oral administration of Filipendula ulmaria extract dissolved in tap water to reach a final concentration of 100 mg/kg b.w. for seven consecutive days. Results: Simultaneous administration of hyperbaric oxygen therapy and antioxidant supplementation with Filipendula ulmaria extract significantly ameliorated the macroscopic and histopathological characteristics of the wound area and healing. Also, this therapeutic approach decreased the local expression of genes for proinflammatory mediators and increased the expression of the µ-opioid receptor and the MT1 and MT2 receptors in the wound area and spinal cord, with a consequent increase in reaction times in behavioural testing. Conclusions: In conclusion, the presented results of our study allow evidence for the advantages of the simultaneous employment of HBO and antioxidant supplementation in the treatment of thermal skin injuries, with special reference to the attenuation of painful sensations accompanied by this type of trauma.


Asunto(s)
Quemaduras , Filipendula , Oxigenoterapia Hiperbárica , Masculino , Animales , Ratas , Ratas Wistar , Antioxidantes/uso terapéutico , Nocicepción , Cicatrización de Heridas , Oxígeno , Suplementos Dietéticos , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico
2.
Oxid Med Cell Longev ; 2021: 8207283, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34447488

RESUMEN

The aim of this study was to investigate and compare the systemic toxicity of three nanosized calcium phosphates (CaPs): hydroxyapatite (HA), tricalcium phosphate (TCP), and amorphous calcium phosphate (ACP) in rats. Since those metallic compounds are widely used as bone replacement materials, including their use in oral surgery, CaPs were applied (per os) equimollary (17.8 mg/kg, 11 mg/kg, and 9.65 mg/kg b.w., respectively) for 30 days in order to mimic the previously described release rate from dental composites. Also, we employed antioxidant supplementation with Filipendula ulmaria (FU) extract. All the applied CaPs significantly increased serum calcium, triglycerides, LDL, and LDH, while serum levels of testosterone and LH declined, with no alterations in the liver enzymes. The evaluation of oxidative stress markers (in the liver, kidney, and testicle) showed an increase in TBARS values, while SOD and CAT activities and GSH levels were significantly reduced. The relative gene expression of Bax and Bcl-2 was shifted to proapoptotic action, accompanied by intense characteristic histological changes in architecture in all investigated organs. The toxic effects were most prominent in groups treated by ACP. FU administration attenuated the majority of nanosized CaP-induced adverse effects, thus recommending this therapeutic approach to minimize nano-CaP systemic toxicities.


Asunto(s)
Antioxidantes , Fosfatos de Calcio/efectos adversos , Filipendula/química , Nanoestructuras/efectos adversos , Extractos Vegetales , Animales , Antioxidantes/química , Antioxidantes/farmacología , Fosfatos de Calcio/farmacología , Masculino , Extractos Vegetales/química , Extractos Vegetales/farmacología , Ratas , Ratas Wistar
4.
Oxid Med Cell Longev ; 2021: 6670135, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-33628375

RESUMEN

Mineral components of dental composites are used in many medical and dental applications, including preventive, restorative, and regenerative dentistry. To evaluate the behavioural alterations induced by nanosized particles of novel dental composites, by means of depressive level and cognitive functions, experimental groups of rats were chronically administered with nanosized hydroxyapatite (HA), tricalcium phosphate (TCP), and amorphous calcium phosphate (ACP) with or without simultaneous application of Filipendula ulmaria L. (FU) methanolic extract. The significant prodepressant action was observed in groups solely treated with HA and ACP. Besides, prolonged treatment with ACP also resulted in a significant decline in cognitive functions estimated in the novel object recognition test. The adverse impact of calcium phosphates on estimated behavioural functions was accompanied by increased oxidative damage and apoptotic markers in the prefrontal cortex, as well as diminished specific neurotrophin (BDNF) and gabaergic expression. The results of our investigation showed that simultaneous antioxidant supplementation with FU extract prevented calcium phosphate-induced behavioural disturbances, as well as prooxidative and apoptotic actions, with the simultaneous restoration of BDNF and GABA-A receptors in the prefrontal cortex. These findings suggest that FU may be useful in the prevention of prodepressant impact and cognitive decline as early as the manifestation of calcium phosphate-induced neurotoxicity.


Asunto(s)
Fosfatos de Calcio/toxicidad , Disfunción Cognitiva/tratamiento farmacológico , Disfunción Cognitiva/prevención & control , Depresión/tratamiento farmacológico , Depresión/prevención & control , Filipendula/química , Nanopartículas/toxicidad , Extractos Vegetales/uso terapéutico , Animales , Apoptosis/efectos de los fármacos , Apoptosis/genética , Factor Neurotrófico Derivado del Encéfalo/metabolismo , Disfunción Cognitiva/complicaciones , Disfunción Cognitiva/genética , Depresión/complicaciones , Depresión/genética , Regulación de la Expresión Génica/efectos de los fármacos , Suspensión Trasera , Masculino , Prueba de Campo Abierto , Estrés Oxidativo/efectos de los fármacos , Estrés Oxidativo/genética , Extractos Vegetales/farmacología , Ratas Wistar , Ácido gamma-Aminobutírico/metabolismo
5.
J Integr Neurosci ; 20(4): 871-883, 2021 Dec 30.
Artículo en Inglés | MEDLINE | ID: mdl-34997711

RESUMEN

We evaluated the influence of an antioxidant-rich extract of Filipendula ulmaria L. on anxiety levels induced by nano-sized particles of different calcium phosphates. Rats in experimental groups were administered with either nano-sized hydroxyapatite, tricalcium phosphate, or amorphous calcium phosphate in the presence of Filipendula ulmaria extract. Appropriate behavioral tests were performed to assess anxiety levels, while oxidative status and apoptosis parameters were determined in the hippocampus samples. The applied calcium phosphates increased oxidative stress markers in hippocampal tissue, accompanied by an enhanced pro-apoptotic mechanism. Moreover, the hippocampal immunoreactivity for brain-derived neurotrophic factor and GABAergic-A receptors was significantly lower following calcium phosphate nanoparticles intake. The observed functional and morphological alterations in the rat hippocampus occurred simultaneously with the anxiogenic response estimated in behavioral testing. The neuroprotective effect of Filipendula ulmaria was markedly manifested by the attenuation of oxidative damage induced by amorphous calcium phosphate and enhanced anti-apoptotic action in the rat hippocampus. The increased hippocampal immunoreactivity for brain-derived neurotrophic factor, GABAergic-A receptors and significant anxiolytic-like effects of Filipendula ulmaria may suggest a beneficial role of antioxidant supplementation in preventing anxiogenic response to nano-sized calcium phosphates.


Asunto(s)
Antioxidantes/farmacología , Ansiedad/tratamiento farmacológico , Apoptosis/efectos de los fármacos , Filipendula , Hipocampo/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Extractos Vegetales/farmacología , Animales , Ansiedad/inducido químicamente , Conducta Animal/efectos de los fármacos , Fosfatos de Calcio/administración & dosificación , Masculino , Nanopartículas/administración & dosificación , Ratas , Ratas Wistar
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA